These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 8314363
1. Population pharmacokinetic analysis of new aminoglycosides, astromicin and isepamicin, and evaluation of Bayesian prediction method for approximation of individual clearance of drug. Uematsu T. Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):606-10. PubMed ID: 8314363 [Abstract] [Full Text] [Related]
2. Pharmacokinetics of isepamicin. Barr WH, Colucci R, Radwanski E, Zampaglione N, Cutler D, Lin CC, Elliott M, Affrime MB. J Chemother; 1995 Jun; 7 Suppl 2():53-61. PubMed ID: 8622111 [Abstract] [Full Text] [Related]
3. Population pharmacokinetics of gentamicin in horses. Martín-Jiménez T, Papich MG, Riviere JE. Am J Vet Res; 1998 Dec; 59(12):1589-98. PubMed ID: 9858412 [Abstract] [Full Text] [Related]
4. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. Zhou H, Mayer PR, Wajdula J, Fatenejad S. J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641 [Abstract] [Full Text] [Related]
5. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A. Bolon-Larger M, Chamouard V, Bressolle F, Boulieu R. Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146 [Abstract] [Full Text] [Related]
6. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Matthews I, Kirkpatrick C, Holford N. Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987 [Abstract] [Full Text] [Related]
7. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA. Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [Abstract] [Full Text] [Related]
8. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients. Irtan S, Saint-Marcoux F, Rousseau A, Zhang D, Leroy V, Marquet P, Jacqz-Aigrain E. Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156 [Abstract] [Full Text] [Related]
9. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis. Terziivanov D, Atanasova I, Dimitrova V, Robeva R, Unger S, Mück W. Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143 [Abstract] [Full Text] [Related]
10. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing. Xuan D, Nicolau DP, Nightingale CH. Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971 [Abstract] [Full Text] [Related]
11. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy. Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan kH, Leblond V, Lechat P. Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531 [Abstract] [Full Text] [Related]
12. Population pharmacokinetics of gentamicin in premature newborns. García B, Barcia E, Pérez F, Molina IT. J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742 [Abstract] [Full Text] [Related]
16. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients. Latz JE, Chaudhary A, Ghosh A, Johnson RD. Cancer Chemother Pharmacol; 2006 Apr; 57(4):401-11. PubMed ID: 16322991 [Abstract] [Full Text] [Related]